[1] Sultana, N., Begum, H.A., et al. (2011) Perception of Genital Cancer among Women Attending the OPD of Tertiary Care Hospital in Old Part of Dhaka City. Journal of Dhaka National Medical College & Hospital, 17, 45-57.
[2] Hussain, A.S. and Sullivan, R. (2013) Cancer Control in Bangladesh. Japanese Journal of Clinical Oncology, 43, 1159-1169.
https://doi.org/10.1093/jjco/hyt140
[3] Ferlay, J., Hery, C., Autier, P. and Sankaranarayanan, R. (2010) Global Burden of Breast Cancer. In: Li, C., Ed., Breast Cancer Epidemiology, Springer, New York, 1-19.
https://doi.org/10.1007/978-1-4419-0685-4_1
[4] Tavassoli, F.A., et al. (2003) World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of the Breast and Female Genital Organs. Vol. 5, IARC Press, Lyon, 14-15.
[5] Siegel, R., Naishadham, D. and Jemal, A. (2013) Cancer Statistics, 2013. CA: A Cancer Journal for Clinicians, 63, 11-30.
https://doi.org/10.3322/caac.21166
[6] Weiss, J.R., Moysich, K.B. and Swede, H. (2005) Epidemiology of Male Breast Cancer. Cancer Epidemiology, Biomarkers & Prevention, 14, 20-26.
[7] Deb, S., Jene, N., kConFab investigators and Fox, S.B. (2012) Genotypic and Phenotypic Analysis of Familial Male Breast Cancer Shows under Representation of the HER2 and Basal Subtypes in BRCA-Associated Carcinomas. BMC Cancer, 12, 510-537.
https://doi.org/10.1186/1471-2407-12-510
[8] Davis, N.M., Melissa Sokolosky, M., et al. (2015) Deregulation of the EGFR/PI3K/ PTEN/Akt/mTORC1 Pathway in Breast Cancer: Possibilities for Therapeutic Intervention. Oncotarget, 5, 4603-4650.
https://doi.org/10.18632/oncotarget.2209
[9] (2014) American Cancer Society. Detailed Guide: Breast Cancer.
http://www.cancer.org/Cancer/BreastCancer/DetailedGuide/index
[10] Angelis, D.R., Tavilla, A., et al. (2016) Breast Cancer Survivors in the United States: Geographic Variability and time Trends, 2005-2015. Cancer, 115, 1954-1966.
https://doi.org/10.1002/cncr.24217
[11] Rosedale, M. and Fu, M.R. (2010) Confronting the Unexpected: Temporal, Situational, and Attributive Dimensions of Distressing Symptom Experience for Breast Cancer Survivors. Oncology Nursing Forum, 37, 28-33.
https://doi.org/10.1188/10.onf.e28-e33
[12] Bodai, B.I. and Tuso, F. (2015) Breast Cancer Survivorship: A Comprehensive Review of Long-Term Medical Issues and Lifestyle Recommendations. The Permanente Journal, 19, 48-79.
https://doi.org/10.7812/TPP/14-241
[13] Howell, A., Anderson, A.S., et al. (2014) Risk Determination and Prevention of Breast Cancer. Breast Cancer Research, 16, 446-457.
https://doi.org/10.1186/s13058-014-0446-2
[14] Li, J., Lindstro, L.S., et al. (2014) 2q36.3 Is Associated with Prognosis for Oestrogen Receptor-Negative Breast Cancer Patients Treated with Chemotherapy. Nature Communications, 5, Article No. 4051.
[15] Morandi, A., Martin, L., et al. (2013) GDNF-RET Signaling in ER-Positive Breast Cancers Is a Key Determinant of Response and Resistance to Aromatase Inhibitors. Cancer Research, 73, 3783-3795.
https://doi.org/10.1158/0008-5472.CAN-12-4265
[16] Pettersson, A., Graff, R.E., et al. (2014) Mammographic Density Phenotypes and Risk of Breast Cancer: A Meta-analysis. Journal of the National Cancer Institute, 106, 112-123.
https://doi.org/10.1093/jnci/dju078
[17] Maguire, S.L., Leonidou, A., et al. (2015) SF3B1 Mutations Constitute a Novel Therapeutic Target in Breast Cancer. Journal of Pathology, 235, 571-580.
https://doi.org/10.1002/path.4483
[18] Sawyer, E., Roylance, R., et al. (2014) Genetic Predisposition to in Situ and Invasive Lobular Carcinoma of the Breast. PLoS Genetics, 10, e1004285.
https://doi.org/10.1371/journal.pgen.1004285
[19] Mousavi, S.M., Gouya, M.M., et al. (2009) Cancer Incidence and Mortality in Iran. Annals of Oncology, 20, 556-563.
https://doi.org/10.1093/annonc/mdn642
[20] Sarfo, A.L., Awuah-Peasah, D., Acheampong, E. and Asamoah, F. (2012) Knowledge, Attitude, and Practice of Self-Breast Examination among Female University Students at Presbyterian University College, Ghana. American Journal of Research Communication, 1, 395-396.
[21] Faronbi, J.O. and Abolade, J. (2012) Breast Self-Examination Practices among Female Secondary School Teachers in a Rural Community in Oyo State, Nigeria. Open Journal of Nursing, 2, 111-115.
http://dx.doi.org/10.4236/ojn.2012.22017
[22] ARC (2012) GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012.
http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx
[23] De Vito, C., Angeloni, C., et al. (2014) A Large Cross-Sectional Survey Investigating the Knowledge of Cervical Cancer Risk Etiology and the Predictors of the Adherence to Cervical Cancer Screening Related to Mass Media Campaign. Bio-Med Research International, 2014, Article ID: 304602.
[24] Lopez, A.J.G. and Lopez, J.A. (2014) Multistep Model of Cervical Cancer: Participation of miRNAs and Coding Genes. International Journal of Molecular Sciences, 15, 15700-15733.
https://doi.org/10.3390/ijms150915700
[25] Parkin, D.M., Bray, F., Ferlay, J. and Pisani, P. (2001) Estimating the World Cancer Burden: Globocan 2000. International Journal of Cancer, 94, 153-156.
https://doi.org/10.1002/ijc.1440
[26] Chakrabarti, O. and Krishna, S. (2003) Molecular Interactions of “High Risk” Human Papillomaviruses E6 and E7 Oncoproteins: Implications for Tumour Progression. Journal of Biosciences, 28, 337-348.
https://doi.org/10.1007/bf02970152
[27] Maio, D. and Liao, J.B. (2006) Human Papillomaviruses and Cervical Cancer. Advances in Virus Research, 66, 125-159.
[28] Huang, R.L., Chang, C.C., et al. (2012) Methylomic Analysis Identifies Frequent DNA Methylation of Zinc Finger Protein 582 (ZNF582) in Cervical Neoplasms. PLoS ONE, 7, e41060.
https://doi.org/10.1371/journal.pone.0041060
[29] Forouzanfar, M.H., Foreman, K.J., et al. (2011) Breast and Cervical Cancer in 187 Countries between 1980 and 2010: A Systematic Analysis. The Lancet, 378, 1461-1484.
https://doi.org/10.1016/S0140-6736(11)61351-2
[30] Walboomers, J.M., Jacobs, M.V., et al. (1999) Human Papillomavirus Is a Necessary Cause of Invasive Cervical Cancer Worldwide. The Journal of Pathology, 189, 12-19.
https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
[31] Miller, J.W., Hanson, V., Johnson, G.D., Royalty, J.E. and Richardson, L.C. (2014) From Cancer Screening to Treatment: Service Delivery and Referral in the National Breast and Cervical Cancer Early Detection Program. Cancer, 120, 2549-2556.
https://doi.org/10.1002/cncr.28823
[32] Tabatabai, M.A., Keumo, J.J.K., et al. (2014) Disparities in Cervical Cancer Mortality Rates as Determined by the Longitudinal Hyperbolastic Mixed-Effects Type II Model. PLoS ONE, 9, e107242.
https://doi.org/10.1371/journal.pone.0107242
[33] Mwaka, A.D., Wabinga, H.R. and Mayanja-Kizza, H. (2014) Mind the Gaps: A Qualitative Study of Perceptions of Healthcare Professionals on Challenges and Proposed Remedies for Cervical Cancer Help-Seeking in Post Conflict Northern Uganda. BMC Family Practice, 14, 193.
[34] Mackay, H.J., Wenzel, L. and Mileshkin, L. (2015) Nonsurgical Management of Cervical Cancer: Locally Advanced, Recurrent, and Metastatic Disease, Survivorship, and Beyond. American Society of Clinical Oncology-Educational Book, 299-309.
https://doi.org/10.14694/EdBook_AM.2015.35.e299
[35] Min, K.J., Lee, Y.J., et al. (2015) The Korean Guideline for Cervical Cancer Screening. Journal of Gynecologic Oncology, 26, 232-239.
https://doi.org/10.3802/jgo.2015.26.3.232
[36] Bourgioti, C., Chatoupis, K., et al. (2016) Current Imaging Strategies for the Evaluation of Uterine Cervical Cancer. World Journal of Radiology, 8, 342-354.
https://doi.org/10.4329/wjr.v8.i4.342
[37] American Cancer Society (2015) Cancer Facts & Figures 2015. American Cancer Society, Atlanta.
[38] Institute for Health Metrics and Evaluation (2011) The Challenge Ahead: Progress and Setbacks in Breast and Cervical Cancer. IHME, Seattle, WA.
[39] Ekechi, C., Olaitan, A., et al. (2014) Knowledge of Cervical Cancer and Attendance at Cervical Cancer Screening: A Survey of Black Women in London. BMC Public Health, 14, 1096.
https://doi.org/10.1186/1471-2458-14-1096
[40] Lemlem, B.S., Sinishaw, W., et al. (2013) Assessment of Knowledge of Breast Cancer and Screening Methods among Nurses in University Hospitals in Addis Ababa, Ethiopia, 2011. ISRN Oncology, 2013, Article ID: 470981.
https://doi.org/10.1155/2013/470981
[41] Fotedar, V., Seam, K.R., et al. (2013) Knowledge of Risk Factors & Early Detection Methods and Practices towards Breast Cancer among Nurses in Indira Gandhi Medical College, Shimla, Himachal Pradesh, India. Asian Pacific Journal of Cancer Prevention, 14, 117-120.
https://doi.org/10.7314/APJCP.2013.14.1.117
[42] Ralston, D.J., Taylor, M.V., et al. (2006) Knowledge of Cervical Cancer Risk Factors among Chinese Immigrants in Seattle. Journal of Tropical Medicine, 28, 41-57.
[43] Uddin, K.F.A., Khan, J.Z., Islam, J. and Mahmud, A.M. (2013) Cancer Care Scenario in Bangladesh. South Asian Journal of Cancer, 2, 102-104.
https://doi.org/10.4103/2278-330X.110510
[44] Madanat, H. and Merrill, M.R. (2002) Breast Cancer Risk-factor and Screening Awareness among Women Nurses and Teachers in Amman, Jordan. Cancer Nursing, 25, 276-282.
https://doi.org/10.1097/00002820-200208000-00003
[45] Lewitowicz, P., Horecka-Lewitowicz, A. and Adamczyk-Gruszka, O. (2013) Knowledge of Cervical Cancer Risk Factors among Students at the Jan Kochanowski University in Kielce. Studia Medyczne, 29, 255-259.
https://doi.org/10.5114/ms.2013.38582
[46] Facione, N.C. (1993) Delay versus Help Seeking for Breast Cancer Symptoms: A Critical Review of the Literature on Patient and Provider Delay. Social Science & Medicine, 36, 1521-1534.
[47] Hussain, A.S. and Sullivan, R. (2013) Cancer Control in Bangladesh. Japanese Journal of Clinical Oncology, 43, 1159-1169.
[48] Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J.W.W., Comber, H., Forman, D. and Bray, F. (2013) Cancer Incidence and Mortality Patterns in Europe: Estimates for 40 Countries in 2012. European Journal of Cancer, 49, 1374-1403.
http://dx.doi.org/10.1016/j.ejca.2012.12.027
[49] Peralta-Zaragoza, O., Bermúdez-Morales, H.V., et al. (2012) Targeted Treatments for Cervical Cancer: A Review. OncoTargets and Therapy, 5, 315-328.